Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Laparoscopic Minimally Invasive Leftsided Pancreatecomy

Research Leaders

13 sponsors active, led by IRCCS San Raffaele

Related Conditions

Often studied with 10 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 5 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 3 (1)

Trial Status

Completed3
Not Yet Recruiting1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (5)

Research Network

Common Treatments

  • Laparoscopic Minimally Invasive Leftsided Pancreatecomy1
  • Robotassisted Minimally Invasive Leftsided Pancreatecomy1
  • Endo Gia Articulating Reinforced Reload With Tristaple Technology1
  • Endo Gia Xtra Thick Reload With Tri Staple Technology1
  • 3 Days Discharge1

Active Sponsors

  • IRCCS San Raffaele1
  • Maastricht University Medical Center1
  • Onze Lieve Vrouwe Gasthuis1
  • Rennes University Hospital1
  • Catharina Ziekenhuis Eindhoven1

Top Investigators

Related Conditions

  • Pancreatectomy2
  • Pancreatic Neoplasms2
  • Minimally Invasive Distal Pancreatectomy1
  • Minimally Invasive Surgery1
  • Minimally Invasive Surgical Technique1

Activity Timeline